Island Pharmaceuticals Ltd (AU:ILA) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Island Pharmaceuticals Ltd announces the departure of Dr. Paul MacLeman as a director, effective November 19, 2024. Dr. MacLeman held a notable interest in the company, including 118,625 shares and options set to expire in March 2025. This change in leadership may influence market perceptions and investor sentiment towards Island Pharmaceuticals.
For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.